QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
16. August 2023 08:00 ET
|
QSAM Biosciences Inc.
AUSTIN, Texas, Aug. 16, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...